|
|
|
Volumn 3, Issue 2, 2000, Pages 119-130
|
|
Future directions in endocrine therapy for the treatment and prevention of breast cancer
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (1,2 DIPHENYL 1 BUTENYL)CINNAMIC ACID;
4 [4 METHYL 2 [4 [2 (1 PIPERIDINYL)ETHOXY]PHENYL] 7 PIVALOYLOXY 2H 1 BENZOPYRAN 3 YLPHENYL] PIVALATE;
ACOLBIFENE;
ANTIESTROGEN;
AROMATASE INHIBITOR;
ARZOXIFENE;
EM 219;
ESTROGEN RECEPTOR;
FULVESTRANT;
LASOFOXIFENE;
N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
TOREMIFENE;
UNCLASSIFIED DRUG;
BREAST CANCER;
CLINICAL TRIAL;
DRUG CONFORMATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
ENDOMETRIUM CARCINOMA;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
REVIEW;
STRUCTURE ACTIVITY RELATION;
|
|
EID: 0033912667
PISSN: 10924450
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (89)
|
